anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
In recent years, the relationship between the microbiota and various aspects of health has become a focal point of scientific investigation. Although the most studied microbiota concern the gastrointestinal tract, recently, the interest has also been extended to other body districts. Female genital tract dysbiosis and its possible impact on pathologies such as endometriosis, polycystic ovary syndrome (PCOS), pelvic inflammatory disease (PID), and gynecological cancers have been unveiled. The incursion of pathogenic microbes alters the ecological equilibrium of the vagina, triggering inflammation and compromising immune defense, potentially fostering an environment conducive to cancer development. The most common types of gynecological cancer include cervical, endometrial, and ovarian cancer, which occur in women of any age but especially in postmenopausal women. Several studies highlighted that a low presence of lactobacilli at the vaginal level, and consequently, in related areas (such as the endometrium and ovary), correlates with a higher risk of gynecological pathology and likely contributes to increased incidence and worse prognosis of gynecological cancers. The complex interplay between microbial communities and the development, progression, and treatment of gynecologic malignancies is a burgeoning field not yet fully understood. The intricate crosstalk between the gut microbiota and systemic inflammation introduces a new dimension to our understanding of gynecologic cancers. The objective of this review is to focus attention on the association between vaginal microbiota and gynecological malignancies and provide detailed knowledge for future diagnostic and therapeutic strategies.
BACKGROUND: Standardized training for pain, agitation-sedation, and delirium (PAD) management is urgently needed for Chinese intensivists' continuing education. Since 2020, because of the COVID-19 pandemic, the Chinese Analgesia and Sedation Education and Research (CASER) group has used an online blended teaching mode based on a small private online course (SPOC) and case-based learning (CBL). This study evaluated whether an online blended teaching mode has similar effects on PAD management training when an offline mode cannot be used.
MATERIALS AND METHODS: Since 2020, the CASER group has provided offline training and online SPOC&CBL training three times each, targeting intensivists and ICU nurses in China. All participants were divided into an offline group and SPOC&CBL group. A final examination was offered in each training session to assess the students' mastery of professional knowledge. Teachers' and students' perceptions regarding the online SPOC&CBL mode were evaluated through questionnaires.
RESULTS: Of all participants (n = 117), 106 completed all examinations and questionnaires. Most participants were aged 31-40 years (53, 50.0%), had an academic degree (60, 56.6%), and worked in a tertiary hospital (100, 94.34%). We assessed the learning effect on participants from two aspects: theory and clinical practice. There was no significant difference between the SPOC&CBL and offline groups in terms of theoretical, case analysis, and total scores (p > 0.05). In terms of the participants' perceptions regarding the SPOC&CBL mode, 91.5% considered the online mode to be a useful and accessible alternative to improve knowledge and skills. A total of 95.7% of the participants believed that they could interact well with group members, and 87.2% believed that they had a good degree of participation. Of these participants, 76.6% believed that they had received valuable learning resources. All instructors believed that the SPOC&CBL mode was more flexible than the offline mode in terms of teaching time and location, and they were all willing to carry out training with the SPOC&CBL mode.
CONCLUSION: Compared to the offline mode, the SPOC&CBL mode can also enhance participants' knowledge and skills and meets their expectations. Therefore, an online mode can be considered a potential method in PAD management education in China.
This is a split body study. Bilateral erector spinae plane catheters will be inserted and study fluid is administered bilaterally. Bupivacaine 0.25 will be administered through the right-sided catheter while normal saline will be administered through the left-sided catheter. Both infusion pumps will be programmed to deliver a basal infusion of 1 mL/h and an automatic intermittent bolus of 20 mL every 4 hours.
The purpose of this study is to determine if Maestro can be used to detect heart arrhythmias, specifically atrial fibrillation in humans. Maestro will be used to measure heart rate and rhythm at the same time that patients are being monitored with a standard 3, 5, or 12 lead electrocardiogram (ECG) in a clinical setting. The recorded Maestro results will be compared to the ECG results to assess Maestro's accuracy.

Data will be analyzed by a pass/fail criterial. The data will be downloaded and printed for the investigators' interpretation who will first review and code the data from Meastro, blinded to the ECG findings. Then the investigators will interpret the ECG findings and the 2 sets of data will be compared. The ECG result is the true value with which to compare the Maestro result.
Participants will have their blood pressure taken by an automated blood pressure device by dialysis unit staff using regular dialysis unit equipment according to usual clinical care. Pre-dialysis blood pressures will be reviewed every two weeks and dry weight and medications adjusted accordingly to reach a pre-dialysis systolic blood pressure target of \<140 mmHg.
In the shape training intervention, infants will be presented with four novel words paired with four novel sets of objects. Each set consists of two exemplars with the same shape but with different colors and textures, and a contrasting object. Each set will be presented in a play session, and the name of the objects will be mentioned at least 10 times. The other three sets of exemplars will be presented in the same way. Each session will last 15 minutes. This intervention is based on a study conducted by Smith and colleagues (2002), where they found that typically developing infants that are taught to attend to shape at 17 months old, can enhance significantly their word learning.
In clinical trials, generally mild and transient burning and stinging followed application with permethrin cream, 5% in 10% of patients and was associated with the severity of infestation. Pruritus was reported in 7% of patients at various times post-application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients (see PRECAUTIONS \- General). Other adverse events reported since marketing permethrin cream, 5% include: headache, fever, dizziness, abdominal pain, diarrhea and nausea and/or vomiting. Although extremely uncommon and not expected when used as directed (see DOSAGE AND ADMINISTRATION), rare occurrences of seizure have been reported. None have been medically confirmed as associated with Permethrin Cream, 5% treatment.
A skin whitening cosmetic composition containing sticopus japonicus extract is provided to show high inhibition effect corresponding to 69% tyrosinase inhibition effect comparison to that of the kojic acid which is the positive control group. A skin whitening cosmetic composition comprises a sticopus japonicus extract as an active ingredient. The extracts are extracted by using the hydrophilic solvent. The hydrophilic solvent is the water or the water-soluble ethanol. The extracts are extracted through the reflux extraction or the solvent acceleration extraction. The sticopus japonicus extract is the residual powder after collecting the extract from sticopus japonicus and evaporating the solvent.
Participants will receive oral doses of two placebo tablets taken with water. Multiple doses will be administered over a 48-hour period.
PURPOSE:To provide an analgesic food by using powder of pear fruit and/or powder of pear fruit juice as essential component. CONSTITUTION:The fruit of gear (an arborescent deciduous tree of Rosaceae family) is subjected to the pretreatment such as washing, removal of foreign material such as dust, etc. The fruit is then crushed together with 5-10 times volume of water optionally after skinning. As an alternative method, the fruit is cut to small pieces without adding water, freeze-dried, and pulverized. The freeze-dried powder is used as an essential component of the objective analgesic food. In the case of crushing the fruit with water without skinning, the crushed product is filtered to remove the coarse pieces of the skin. The analgesic food may be a cake, refreshing drink, candy, powder, granule, etc. It is administered at a dose of 50-300mg/kg daily. EFFECT:An analgesic food absolutely free from side effects, and having remarkable remedying effect against the gain of throat in bronchial asthma, etc.
PURPOSE:To obtain fine particles excellent in water repellency for which catalytic activity sealed is and secondary aggregation is reduced by mixing fine particles and methylhydrodiene polyisiloxane having a specified structure, then heating the mixture in two stages. CONSTITUTION:Fine particles and methylhydrodiene polysiloxane expressed by formula I (wherein (m) and (n) are average numbers satisfying m+n=7 to 25 and m:n=1:(2 to 4)) are mixed. The mixture is subjected to primary heating treatment at 60-130 deg.C for 0.5-4 hours, and then succeedingly subjected to secondary heat treatment at higher temp. than the temp. of primary heating treatment and at 110-200 deg.C for 1-8 hours. The reformed fine particles thus obtd. can be used as a cosmetic material excellent in quality stability and feeling.
In the study arm, infants will not receive PCV13, DTaP, HBV, IPV, and Hib vaccines during the study. Infants will be monitored from randomization to 48 hours post-randomization for the occurrence of apnea, bradycardia and desaturation.
A Nelumbo nuficera extract having treatment effect on dermatitis is provided to promote melanogenesis, enhance tyrosinase activity and prevent and treat pigmentary disorder. A Nelumbo nuficera extract is isolated with n-hexane and have treatment effect on pigmentary disorder including vitiligo, white lentigo, depigmentation after inflammation, and photosensitive skin disorder. The Nelumbo nuficera is petals or stamens of Nelumbo nuficera. A Nelumbo nuficera extract essential oil is obtained by extracting and filtering the Nelumbo nuficera with n-hexane, evaporating at 40~60°C and removing hexane in vacuum. The essential oil comprises palmitic acid, linoleic acie, and their methyl ester. A therapeutic composition of pigmentary skin disorder comprises the essential oil of Nelumbo nuficera extract or palmitic acid methyl ester.
Capsular saccharides are typically anionic. In the invention, however, cationic groups are introduced, such that the modified saccharide has a repeating unit which includes both cationic and anionic groups. These cationic and anionic groups can be balanced to give a zwitterionic repeating unit. These modifications can convert a saccharide that is normally a T-independent antigen into one that can activate T cells without requiring conjugation to a carrier. Typically, the invention modifies an anionic bacterial capsular saccharide antigen by converting a neutral group in the saccharide into a cationic group e.g. to change —NHAc to —NH 3   + .
Osteoarthritis (OA) is the most common form of chronic joint disease. Platelet Rich Plasma (PRP) is an injection therapy used to treat chronic painful musculoskeletal conditions, including knee OA. In this prospective, randomized controlled, single blind, interventional study, a total of 75 patients with stage 2-3 knee osteoarthritis according to the kellgren lawrence classification who meet the eligibility criteria will be enrolled in the study. Eligible participants will be randomly assigned to one of the three groups using computer-generated random numbers.The patients to be included in the study will be randomized into three groups and the first group will be given platelet-rich plasma (PRP) prepared with T-LAB / PRP KIT, the second group will be given PRP prepared with T-LAB PRP INJECTION SYRINGA, and the third group will be given saline injection. Home exercise program for knee osteoarthritis will be given to all three groups and the exercise program will be followed by weekly phone calls. During the follow-up period, patients will be asked to continue their current medical treatments, not to make changes in their activities of daily living. Participants are going to evaluate before injection, and at the 1-month follow-up and 6-month follow-up using the visual analog scale (VAS) scores for pain during activity, at rest, and at night, with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) change in pain, stiffness and physical function score, the change in the Timed Up and Go Test (TUG) time, change in femoral cartilage thickness measurement by ultrasound and the change in the patient's daily activities with the numerical global patient assessment scale.
BACKGROUND/AIM: Breast-conserving surgery is the preferred treatment for early-stage breast cancer but can often result in unsatisfactory cosmetic outcomes. Oncoplastic surgery aims to improve both oncologic and aesthetic outcomes by combining local excision with plastic surgery techniques. Using breast reduction techniques in breast cancer treatment has been shown to allow for wider margins of excision, leading to enhanced oncological safety and reduced recurrence rates without causing significant asymmetry. This study aimed to analyze the surgical and oncological outcomes of a large cohort of patients undergoing oncoplastic reduction mammoplasty (ORM).
PATIENTS AND METHODS: A retrospective analysis of postoperative surgical and oncological outcomes of all patients who underwent ORM at a single center between January 2018 and December 2023 was performed. Preoperative patient characteristics, operative and post-operative outcomes were recorded and analyzed.
RESULTS: A total of 67 patients that underwent oncologic breast reduction were included in the final analysis - representing a total of 71 ORM, with a mean (SD) age of 53.1 (10.5) years and a mean (SD) BMI of 28.8 (5.9) kg/m2 A superomedial pedicle-based technique was the most frequently used (36.6%), followed by inferior pedicle-based technique (28.1%). A complication rate of 18.3% on the ipsilateral side was observed. Salvage surgery was necessary in five cases (7.0%) due to positive margins - with one patient (1.4%) requiring margin expansion surgery and four (5.6%) a completion mastectomy.
CONCLUSION: This monocentric retrospective study shows that ORM is safe, with a complication rate on par with conventional breast reduction and offers satisfactory oncological outcomes.
A substance, having itself no hormone activity but serving to increase the activity of male sexual hormones, which is found in extracts from animal organs and body fluids and from vegetable material, is concentrated and purified by treating a solution thereof in a hydrocarbon, carbon disulphide or a mixture containing one of these, with an adsorbent, and then extracting the activator from the adsorbate by means of an alcohol, ketone, ether, chlorinated hydrocarbon or a solvent mixture containing one of these.  The initial material may be an extract of lipoid or acid character.  The adsorption step may be conducted fractionally or may be repeated after a stage of purification by crystallization from dilute alcohol. According to an example bull's testicles are extracted with alcohol, the extract evaporated and the residue taken up in ether and shaken with dilute alkali.  The alkaline solution is acidified, extracted with ether and the ethereal solution evaporated.  The residue is dissolved in petroleum ether, boiled with "Frankonit" (Registered Trade Mark) and the separated adsorbate boiled with a mixture of alcohol and chloroform to yield a solution which is evaporated leaving a residue resembling stearine and having the property of increasing the action of testosterone when injected simultaneously therewith.  Specification 401,574 is referred to.
NEW MATERIAL:A peptide of formula I (R is acetyl, propionyl, phthalyl, glutaryl or pGlu; A is Ala or Gly, L-Ala, D-Ala, L-Trp or D-Trp; C is Leu, nLeu or Met) and a salt thereof. EXAMPLE:HOOC(CH2)3CO-Ala-Tyr(SO3H)-Gly-Trp-Met-Asp-Phe-NH2. USE:A compound having promoting action on secretion of gastric acid and external secretion of pancreas. PREPARATION:For exmple, a peptide of formula II is sulfated with pyridine- sulfuric acid anhydride complex, and the resultant sulfuric ester is desalted and purified to afford the aimed compound of formula I . The compound of formula I is preferably obtained by carrying out the sulfation in the final stage in the above-mentioned reaction. The above-mentioned reaction has the following advantages; The decomposition of the sulfuric ester bond is minimized, and the amount of by-products is reduced. Thus, the aimed substance is obtained in higher yield and purity.
Aberrant micro-RNA (miRNA) expression profiles have been associated with disease progression and clinical outcome in pediatric cancers. However, few studies have analyzed genome-wide dysregulation of miRNAs and messenger RNAs (mRNAs) in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). To identify novel prognostic factors, we comprehensively investigated miRNA and mRNA sequencing (miRNA-seq and mRNA-seq) data in pediatric BCP-ALL samples with poor outcome. We analyzed 180 patients, including 43 matched pairs at diagnosis and relapse. Consensus clustering of miRNA expression data revealed a distinct profile characterized by mainly downregulation of miRNAs (referred to as an miR-low cluster [MLC]). The MLC profile was not associated with any known genetic subgroups. Intriguingly, patients classified as MLC had significantly shorter event-free survival (median 21 vs 33 months; log-rank P = 3 ×10-5). Furthermore, this poor prognosis was retained even in hyperdiploid ALL. This poor prognostic MLC profiling was confirmed in the validation cohort. Notably, non-MLC profiling at diagnosis (n = 9 of 23; Fisher exact test, P = .039) often changed into MLC profiling at relapse for the same patient. Integrated analysis of miRNA-seq and mRNA-seq data revealed that the transcriptional profile of MLC was characterized by enrichment of MYC target and oxidative phosphorylation genes, reduced intron retention, and low expression of DICER1. Thus, our miRNA-mRNA integration approach yielded a truly unbiased molecular stratification of pediatric BCP-ALL cases based on a novel prognostic miRNA signature, which may lead to better clinical outcomes.
Risk Summary

The limited published data on filgrastim product use during pregnancy are insufficient to inform a drug-associated risk. In animal reproduction studies, administration of tbo-filgrastim to pregnant rabbits during organogenesis resulted in increased spontaneous abortion and fetal malformations at systemic exposures 50 to 90 times the human exposure expected at the recommended human dose (see Data). GRANIX should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

The estimated background risk of major birth defects and miscarriage for the indicated population(s) are unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.

Data

Animal Data

In an embryofetal developmental study, pregnant rabbits were administered subcutaneous doses of tbo-filgrastim during the period of organogenesis at 1, 10 and 100 mcg/kg/day. Increased abortions were evident in rabbits treated with tbo-filgrastim at 100 mcg/kg/day. This dose was maternally toxic as demonstrated by reduced body weight. Other embryofetal findings at this dose level consisted of post-implantation loss‚ decrease in mean live litter size and fetal weight, and fetal malformations such as malformed hind limbs and cleft palate. The dose of 100 mcg/kg/day corresponds to a systemic exposure (AUC) of approximately 50 to 90 times the exposures observed in patients treated with the clinical tbo-filgrastim dose of 5 mcg/kg/day.
BACKGROUND: The COVID-19 pandemic has profoundly affected the care practices of total joint arthroplasty (TJA) throughout the world. However, the impact of the pandemic on TJA care practices has not yet been studied in China.
METHODS: This retrospective multicenter cohort included patients aged 18 years or older who underwent TJA between January 2019 and December 2019 (prepandemic period) and January 2020 to December 2021 (pandemic period). Data were obtained from the medical records of 17 Chinese hospitals. Interrupted time series (ITS) analysis was used to estimate differences in monthly TJA volume, hospitalization proportion of TJA, preoperative characteristics, postoperative complications, 30-day readmissions, length of stay (LOS), and costs in inpatients undergoing TJA between the prepandemic and pandemic periods. Multivariate regression and propensity score matching (PSM) analyses were used to assess the impact of the COVID-19 pandemic on hospital complications, readmissions at 30 days, LOS, and costs at the patient level.
RESULTS: A total of 752,477 inpatients undergoing TJA in the prepandemic period, 1,291,248 in the pandemic period, with an average 13.1% yearly decrease in the volume of TJA during the pandemic. No significant changes were observed in the proportion of hospitalizations for TJA. ITS analyses showed increases in the proportion of comorbidities (8.5%, 95% CI: 3.4-14.0%) and the number of comorbidities (15.6%, 95% CI: 7.7-24.1%) in TJA cases during the pandemic, without increasing LOS, costs, complications, and readmission rates. Multivariate and PSM analyses showed 6% and 26% reductions in costs and readmission rates during the pandemic, respectively.
CONCLUSIONS: The COVID-19 pandemic was associated with more severe preoperative conditions and decreased volume, costs, and readmission rates in patients undergoing TJA in China. These findings demonstrate that the COVID-19 pandemic did not have a dramatic impact on the TJA care pattern in China, which may have resulted from active and strict strategies in combating COVID-19 as well as a rapid response in hospital management.
Segmentectomy with hilar and mediastinal lymph node dissection is performed. If the tumor located at inter-segment plane and without sufficient resection margin distance, a combined segmentectomy will be performed after a comprehensive evaluation. As with lobectomy, systemic or selective lymph node dissection is mandatory, and nodal sampling is not allowed. At least three stations of mediastinal lymph node from 2R, 4R, 7, 8, 9 for the right side and 5, 6, 7, 8, 9 for the left side, respectively. The distance from the dissection margin to the tumor edge must be evaluated in the same manner as with lobectomy.
A silicone elastomer composition (“composition”) has customizable sensory characteristics. The composition includes a pituitous silicone fluid that includes a hydrosilylation reaction product and a carrier fluid. The hydrosilylation reaction product generally includes alkenyl or Si—H functionality. The hydrosilylation reaction product is the reaction product of a first linear organopolysiloxane including (R1R2R3SiO—1/2) and (R4R5Si)2/2) units, and a second linear organopolysiloxane including (R6R7R8SiO—1/2) and (R9R10SiO2/2) units. Each of R1-R10 is independently a hydrocarbon group so long as at least one of R1-R5 is an alkenyl group and at least one of R6-R10 is a hydrogen atom. The first linear organopolysiloxane has a DP of from 100 to 15,000. The second linear organopolysiloxane has a DP of from 4 to 1,000. The composition also includes a silicone elastomer different from the hydrosilylation reaction product. Personal care compositions can include the composition.